Associations between vascular risk factors and brain MRI indices in UK Biobank.
Brain
Cortex
Diffusion
MRI
Vascular risk
White matter
Journal
European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263
Informations de publication
Date de publication:
21 07 2019
21 07 2019
Historique:
received:
08
01
2019
revised:
23
01
2019
accepted:
19
02
2019
pubmed:
12
3
2019
medline:
30
10
2020
entrez:
12
3
2019
Statut:
ppublish
Résumé
Several factors are known to increase risk for cerebrovascular disease and dementia, but there is limited evidence on associations between multiple vascular risk factors (VRFs) and detailed aspects of brain macrostructure and microstructure in large community-dwelling populations across middle and older age. Associations between VRFs (smoking, hypertension, pulse pressure, diabetes, hypercholesterolaemia, body mass index, and waist-hip ratio) and brain structural and diffusion MRI markers were examined in UK Biobank (N = 9722, age range 44-79 years). A larger number of VRFs was associated with greater brain atrophy, lower grey matter volume, and poorer white matter health. Effect sizes were small (brain structural R2 ≤1.8%). Higher aggregate vascular risk was related to multiple regional MRI hallmarks associated with dementia risk: lower frontal and temporal cortical volumes, lower subcortical volumes, higher white matter hyperintensity volumes, and poorer white matter microstructure in association and thalamic pathways. Smoking pack years, hypertension and diabetes showed the most consistent associations across all brain measures. Hypercholesterolaemia was not uniquely associated with any MRI marker. Higher levels of VRFs were associated with poorer brain health across grey and white matter macrostructure and microstructure. Effects are mainly additive, converging upon frontal and temporal cortex, subcortical structures, and specific classes of white matter fibres. Though effect sizes were small, these results emphasize the vulnerability of brain health to vascular factors even in relatively healthy middle and older age, and the potential to partly ameliorate cognitive decline by addressing these malleable risk factors.
Identifiants
pubmed: 30854560
pii: 5371095
doi: 10.1093/eurheartj/ehz100
pmc: PMC6642726
mid: EMS82279
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2290-2300Subventions
Organisme : Medical Research Council
ID : MR/J006971/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12011/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L023784/2
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG054628
Pays : United States
Organisme : Biotechnology and Biological Sciences Research Council
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M013111/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U147585819
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1001245
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R024065/1
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : P2C HD042849
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD083613
Pays : United States
Organisme : Medical Research Council
ID : G0701120
Pays : United Kingdom
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.
Références
Neurobiol Aging. 2004 Aug;25(7):843-51
pubmed: 15212838
Ann Intern Med. 2008 Mar 18;148(6):427-34
pubmed: 18347351
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683
J Neurosci. 2010 Jun 2;30(22):7569-74
pubmed: 20519531
Lancet Neurol. 2010 Jul;9(7):689-701
pubmed: 20610345
Am J Physiol Heart Circ Physiol. 2011 Jan;300(1):H388-96
pubmed: 21057039
Neuropsychology. 2011 May;25(3):368-77
pubmed: 21417532
Stroke. 2011 May;42(5):1255-60
pubmed: 21493917
Lancet Neurol. 2011 Sep;10(9):819-28
pubmed: 21775213
Brain. 2011 Nov;134(Pt 11):3398-407
pubmed: 22075523
J Alzheimers Dis. 2012;32(3):553-67
pubmed: 22842871
Neuroimage. 2013 Jun;73:239-54
pubmed: 22846632
PLoS One. 2012;7(8):e43647
pubmed: 22916287
Aging Ment Health. 2013;17(3):287-92
pubmed: 23215827
Alzheimers Dement. 2013 Jan;9(1):1-11.e3
pubmed: 23305821
J Psychopharmacol. 2013 Sep;27(9):761-70
pubmed: 23884863
Neurology. 2014 Apr 15;82(15):1331-8
pubmed: 24623838
Stroke. 2015 Feb;46(2):425-32
pubmed: 25572411
Alzheimers Res Ther. 2015 Mar 18;7(1):17
pubmed: 25815063
J Alzheimers Dis. 2015;48(3):813-23
pubmed: 26402115
Stroke. 2016 Feb;47(2):410-6
pubmed: 26696646
Age Ageing. 2016 Jan;45(1):14-21
pubmed: 26764391
BMJ Open. 2016 Mar 22;6(3):e009161
pubmed: 27006341
Alzheimer Dis Assoc Disord. 2016 Jul-Sep;30(3):210-5
pubmed: 27556935
Nat Neurosci. 2016 Nov;19(11):1523-1536
pubmed: 27643430
Nat Commun. 2016 Dec 15;7:13629
pubmed: 27976682
Neurobiol Aging. 2017 Jun;54:54-58
pubmed: 28324763
Eur Heart J. 2017 Feb 21;38(8):577-583
pubmed: 28363219
Sci Rep. 2017 Apr 18;7:46263
pubmed: 28417965
Obes Rev. 2017 Jul;18(7):715-723
pubmed: 28489290
Brain Struct Funct. 2017 Dec;222(9):4023-4033
pubmed: 28589258
Am J Epidemiol. 2017 Nov 1;186(9):1026-1034
pubmed: 28641372
Sci Rep. 2017 Jul 14;7(1):5434
pubmed: 28710424
Stroke Vasc Neurol. 2016 Oct 25;1(3):83-92
pubmed: 28959468
Am J Hypertens. 2017 Dec 8;31(1):72-79
pubmed: 28992237
Neuroimage. 2018 Feb 1;166:400-424
pubmed: 29079522
J Am Coll Cardiol. 2018 Feb 20;71(7):809-811
pubmed: 29447745
BMJ Open. 2018 Mar 23;8(3):e019362
pubmed: 29574441
Ann N Y Acad Sci. 2018 Sep;1428(1):89-102
pubmed: 29741211
Cereb Cortex. 2018 Aug 1;28(8):2959-2975
pubmed: 29771288
JAMA. 2018 Aug 21;320(7):657-664
pubmed: 30140876
Neurology. 2018 Oct 16;91(16):e1479-e1486
pubmed: 30232248
Neurology. 2018 Oct 16;91(16):729-730
pubmed: 30232249
Nat Neurosci. 2018 Oct;21(10):1318-1331
pubmed: 30250261
Brain Imaging Behav. 2019 Mar 22;:null
pubmed: 30903549